Get the content you want anytime you want.

Society of Infectious Diseases Pharmacists

Society of Infectious Diseases Pharmacists
Founded in 1990, the Society of Infectious Diseases Pharmacists (SIDP) is an association of pharmacists and allied healthcare professionals dedicated to promoting the appropriate use of antimicrobial agents.

Latest Partner Content

Preliminary Negative Cultures for the De-Escalation of MRSA Therapy
This article evaluates the point in microbiological workup at which results of respiratory secretion and blood cultures could be interpreted as excluding MRSA and, thus, no longer warrant the empirical vancomycin therapy.
Vaginal Microbiome Transplantation Effective in Intractable Bacterial Vaginosis
A recent study reported the benefit of vaginal microbiome transplantation for the treatment of recurrent bacterial vaginosis.
Alternative Antiretroviral Medication Delivery Systems Emerge to Treat, Prevent HIV Infection
Novel modes of delivery are imperative to improve HIV suppression and prevent transmission.
Teaching Old Dogs New Tricks: Make the Most of Twitter to Boost ID Education, Engagement, and Advocacy
Infectious diseases clinicians turn to Twitter as a tool for education and collaboration.
Entering the Ring: Oral Vancomycin Versus Metronidazole for <i>C difficile</i> Infection and the Risk of Vancomycin-Resistant <i>Enterococcus</i>
In 2017, a guideline update stripped metronidazole of its first-line therapy designation and crowned oral vancomycin as initial therapy for all C difficile infection cases.
Changes in Therapy Recommendations in the 2019 ATS/IDSA Guidelines for Community-Acquired Pneumonia
This article highlights some key updates to the antimicrobial therapy recommendations in the updated community-acquired pneumonia guidelines.
By stopping unnecessary antibiotics before they start, clinicians can avoid unnecessary harm to the patient and the population. 
Evaluating the Role of New Beta-Lactam Agents for Uncommon Pathogens
Novel β-lactam/β-lactamase inhibitor combinations and cefiderocol may play a part in the treatment of infections caused by Stenotrophomonas maltophilia, Achromobacter xylosoxidans, and Burkholderia cepacia complex. 
Is there a cure? How long until we find it? And will it work for the majority of people living with HIV?